Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients ...Middle East

PR Newswire - News
Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients
NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of Vibativ® (telavancin) in treating secondary bacterial infections in COVID-19 patients...

Hence then, the article about vibativ effectively helps treat secondary bacterial infections in covid 19 patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News